Vertex Pharmaceuticals Incorporated (VRTX)

Vertex Pharmaceuticals Incorporated is listed in the United States. Sector: Healthcare. Industry: Biotechnology.

Vertex Pharmaceuticals Incorporated (VRTX): research close 534.20 USD on 2026-11-17. 52-week range 421.03 to 558.88 USD. Historical research data, not advice.

Dated company evidence

FactFigureAs of
Historical research close534.20 USD2026-11-17
Previous research close537.79 USD2026-11-16
Change between the two dated research closes-0.67%2026-11-16 – 2026-11-17
Market capitalisation136.49 billion USD2026-11-16
52-week range of the research close421.03 – 558.88 USD2025-11-18 – 2026-11-17
One-year change in the research close23.08%2025-11-17 – 2026-11-17
Average daily turnover (20 sessions)843.31 million USD2026-11-17

Source: us_closes_adjusted · US · research close

Historical research prices; adjustments vary by market. This is not a live quote or a forecast.

Continue your company research

Members can compare available company evidence and explicitly save VRTX to a watchlist. A company is saved only after Save is pressed for it.

Free membership opens nine research tools, starting with the Hotlist: the stocks drawing unusual turnover each session.

Nine member offerings. Free. No card.

Join free

Research, not advice.

Research on this page's measures

Glossary: AVWAP · Date of Control · Beta · Loading · Market cap · Cost of equity · Implied rate

Most-traded US companies

Full list of most-traded US companies